Office of Sponsored Programs
OSP Weekly
03/27/2019
|
|
Please forward and share with other faculty who may be interested.
|
|
Find Funding Opportunities
|
|
 |
Grant Resource Center
Through a subscription with the Grants Resource Center (GRC), a unit of the American Association of State Colleges and Universities, UNLV has access to a comprehensive suite of tools, services, and expertise to improve efficiency and increase success in securing competitive grants from federal and private sponsors. OSP staff will assist faculty in the use of all GRC options:
GrantSearch
- No login required if accessed from any UNLV computer. For off-campus access, email osp@unlv.edu for login and password.
|
|
|
|
UNLV Libraries' Grant Resources
Several sources, right at your fingertips, to begin your search for sponsored program funding:
|
|
|
|
Using Data Analytics to Support Primary Care and Community Interventions to Improve Chronic Disease Prevention and Management and Population Health (R18)
Application Deadline: 05/29/2019
The purpose of this FOA is to invite applications to promote health equity and improve the health of individuals and populations at risk for suboptimal health outcomes through the use of primary care and community interventions that address chronic conditions, including prevention and management of multiple chronic conditions. This is to be accomplished by developing data resources, applying health services research methodologies and presenting data analytics to primary care providers, health care delivery systems, public health departments, and/or community organizations to help them address social determinants of health (SDOH) and contribute to the delivery of whole person, 360-degree care that meets physical, behavioral, and oral health, as well as social services, needs.
|
|
Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Option
Application Deadline: 05/07/2022
The purpose of this Funding Opportunity Announcement (FOA) is to provide support for New Investigators from backgrounds nationally underrepresented in biomedical and behavioral research to conduct small research projects in the scientific mission areas of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The R21 is intended to support small research projects that can be carried out in a short period of time with limited resources and seeks to facilitate the transition to research independence of New Investigators from backgrounds underrepresented in the biomedical and behavioral sciences. The R21 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology.
|
|
DoD Autism Clinical Translational Research Award
Application Deadline: 08/08/2019
The ARP Clinical Translational Research Award is intended to support early-phase, proof-of-principle translational studies that will examine hypothesis-based, innovative interventions that have the potential to address current clinical deficits for ASD. Applications are strongly encouraged to address one of the ARP Clinical Translational Research Award Areas of Interest.
|
|
DoD Autism Clinical Trial Award
Application Deadline: 08/08/2019
T
he ARP Clinical Trial Award supports research with the potential to have a major impact on the treatment or management of ASD. Funding from this award mechanism must support a clinical trial and may not be used for preclinical research studies. It is expected that the proposed clinical trial begin no later than 12 months after the award date, or 18 months after the award date for U.S. Food and Drug Administration (FDA)-regulated studies.
|
|
DoD Autism Idea Development Award
Application Deadline: 08/08/2019
The ARP Idea Development Award supports the development of innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with ASD. This award mechanism is designed to support innovative ideas with the potential to yield impactful data and new avenues of investigation.
|
|
Neurofibromatosis Research Program
|
|
DoD Neurofibromatosis, Clinical Trial Award
Application Deadline: 06/06/2019
The NFRP Clinical Trial Award supports research with the potential to have a major impact on the treatment or management of NF. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first in human, Phase 0), to demonstrate feasibility or inform the design of more advanced trials, through large-scale trials to determine efficacy in relevant patient populations.
|
DoD Neurofibromatosis, Exploration-Hypothesis Development Award
Application Deadline: 06/06/2019
The NFRP Exploration – Hypothesis Development Award supports the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in NF research. Studies supported by this award mechanism are expected to lay the groundwork for future avenues of scientific investigation.
|
|
DoD Neurofibromatosis, Early Investigator Research Award
Application Deadline: 06/06/2019
The Early Investigator Research Award supports NF-focused research opportunities for individuals in the early stages of their careers, under the guidance of a designated Mentor. This opportunity allows for early-stage investigators to develop a research project, investigate a problem or question in NF research, and further their intellectual development as an NF
researcher of the future.
|
DoD Neurofibromatosis, New Investigator Award
Application Deadline: 06/06/2019
The intent of the NFRP New Investigator Award is to support the continued development of promising independent investigators and/or the transition of established investigators from other research fields into a career in the field of NF research. Prior experience in NF research is not required.
|
|
DoD Neurofibromatosis Investigator - Initiated Research Award
Application Deadline: 06/06/2019
The NFRP Investigator-Initiated Research Award supports highly rigorous, high-impact research projects that have the potential to make an important contribution to NF research and/or patient care. Research projects may focus on any phase of research, excluding clinical trials. The rationale for a research idea may be derived from laboratory discovery, population-based studies, a clinician’s firsthand knowledge of patients, or anecdotal data. Applications must include preliminary and/or published data that are relevant to NF and the proposed research project.
|
|
Request for Application (RFA) #4a: Planning Grant
Letter of Intent Deadline: 04/22/2019 -
Full Application Deadline: 06/03/2019
Request for Application (RFA) #4b: Preclinical Study
Letter of Intent Deadline: 05/13/2019 - Full Application Deadline: 07/22/2019
The Pharmacotherapies for Alcohol and Substance Abuse (PASA) consortium is funded by the Alcohol and Substance Abuse Disorders Research Program. The goal of the PASA consortium is to fund study applications for developing new medications that can be brought to therapeutic use to improve treatment outcomes for alcohol and substance use disorders (ASUD), especially as related to post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI). The two upcoming research funding opportunities are focused on:
- Request for Application (RFA) #4a: Small-cost and short-duration planning grant awarded to investigators concerning a specific compound or combination of compounds. Designed to determine the clinical development plan (CDP) and associated studies needed to advance the compound to FDA approval for ASUD treatment.
- Request for Application (RFA) #4b: Full study implementation awards for proof-of-principle basic research to determine which compounds are most appropriate for human research trials.
|
|
|
|
|
|
|
